GlobalData

In Vitro Diagnostics (IVD) - Emerging Countries (Brazil, Russia, India, China) Opportunity Assessment, Competitive Landscape and Market Forecasts to 2018

Lifestyle and Infectious Diseases Encourage In Vitro Diagnostics Market in Emerging Countries

 
Repost This

London, England -- (SBWIRE) -- 06/08/2012 -- The emerging countries of Brazil, Russia, India and China (BRIC) represent a promising region for the diagnostic testing industry, as population growth and unhealthy lifestyles mean the patient population is growing rapidly, according to a new report from healthcare experts GlobalData.

The new report predicts that the in vitro diagnostics (IVD) market will be driven by new technological advancements, a shift towards Point of Care (POC) testing and the adoption of cost cutting measures over the coming years. The ever increasing patient pool, improving healthcare infrastructure, and enhanced health awareness and affordability will also keep the IVD market buoyant in BRIC countries.

The increasing prevalence of lifestyle disorders and emergence of infectious diseases are expected to fuel future growth. In 2009, the Chinese government initiated healthcare reforms that invested $123 billion in the construction of hospitals and healthcare centers within rural areas, providing for many underserved citizens and opening new markets for medical device manufacturers. In addition, with the population of India estimated to exceed 1.7 billion by 2050, surpassing China, the underlying demand for healthcare is anticipated to display a strong boom.

The immunochemistry market accounted for 32% of the total revenue generated by the in vitro diagnostics market of emerging countries last year. Immunochemistry rapid tests are in high demand in the emergency departments of hospitals, as their use is imperative in emergency situations where practitioners must be able to obtain faster test results. BRIC countries are facing the double burden of a high incidence of infectious diseases and an increasing burden of non communicable diseases (NCDs) such as cancer and cardiovascular disorders. The increasing incidence of these diseases in BRIC countries provides opportunity for growth in the immunochemistry industry to cater to increased demand for testing for tumor markers and cardiac markers.

For Sample Pages, please click or add the below link to your browser:

http://www.globaldata.com/ReportStore/RequestSamplePages.aspx?ID=In-Vitro-Diagnostics-IVD-Emerging-Countries-Brazil-Russia-India-China-Opportunity-Assessment-Competitive-Landscape-and-Market-Forecasts-to-2018&CompanyID=sbwirereportstore

The market for In Vitro Diagnostics (IVD) in the BRIC countries is expected to grow at a compound annual growth rate (CAGR) of 16% to reach a revenue of $11.7 billion in 2018. China is the largest in vitro diagnostics market among emerging countries, with a 56% contribution valuing $2.2 billion in 2011; this is expected to reach $7.1 billion by 2018. Brazil was the second largest in vitro diagnostics market among the emerging countries in 2011, valued at $946.1m. During the same year, the Indian in vitro diagnostics market was worth $581.4m, and the Russian in vitro diagnostics market was valued at $267.4m.

This report provides key data, information and analysis on the In Vitro Diagnostics (IVD) market in emerging countries. It provides market landscape, competitive landscape and market trends information on the IVD market in emerging countries. The report also provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics, while reviewing the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis by GlobalData’s team of industry experts

GlobalData is a leading global business intelligence provider offering advanced analytics to help clients make better, more informed decisions every day. Our research and analysis is based on the expert knowledge of over 700 qualified business analysts and 25,000 interviews conducted with industry insiders every year, enabling us to offer the most relevant, reliable and actionable strategic business intelligence available for a wide range of industries.

For further details, please click or add the below link to your browser:
http://www.globaldata.com/ReportStore/Report.aspx?ID=In-Vitro-Diagnostics-IVD-Emerging-Countries-Brazil-Russia-India-China-Opportunity-Assessment-Competitive-Landscape-and-Market-Forecasts-to-2018&CompanyID=sbwirereportstore

Visit our report store: http://www.globaldata.com/reportstore

For more details contact:
pressreleases@globaldata.com

North America:
+1 646 395 5477
Europe:
+44 207 753 4299
+44 1204 543 533
Asia Pacific:
+91 40 6616 6782